Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

British Journal of Cancer

Volumn 86, Issue 6, 2002, Pages 886-892

  Sarela, A I ^a,b   Verbeke, C S ^b   Ramsdale, J ^b   Davies, C L ^a   Markham, A F ^a   Guillou, P J ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

BCL 2; Inhibitor of apoptosis; P53; Pancreatic neoplasms

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; PROTEIN SYNTHESIS INHIBITOR; REGULATOR PROTEIN; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; APOPTOSIS; CELL CYCLE; CELL DIVISION; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037128687     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600133     Document Type: Article

References (48)

1. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
2. Developmentally regulated expression of the novel cancer anti-apoptosis gene Survivin in human and mouse differentiation
3. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer
4. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
5. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting
6. Survivin as a radioresistance factor in pancreatic cancer
7. The expression of Survivin, an inhibitor of apoptosis, in esophageal cancer
8. Inhibition of apoptosis during development of colorectal cancer
9. Prognostic factors in resectable pancreatic cancer: P53 and bcl-2
10. American Gastroenterological Association medical position statement: Epidemiology, diagnosis and treatment of pancreatic ductal adenocarcinoma
11. A matter of life and cell death
12. Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas
13. Apoptosis in cancer therapy: Crossing the threshold
14. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
15. Expression of the apoptosis inhibitor, survivin, in non-melanoma skin cancer and gene targeting in a keratinocyte cancer cell line
16. Cell proliferation and apoptosis
17. P53 in tumor pathology: Can we trust immunohistochemistry? - Revisited!
18. Clinical implications of the p53 tumor-suppressor gene
19. Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma
20. The potential for gene therapy in pancreatic cancer
21. Survivin promotes cell proliferation in hepatocellular carcinomas
22. Escaping cell death: Survival proteins in cancer
23. Expression of survivin in esophageal cancer: Correlation with prognosis and response to chemotherapy
24. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer
25. P53, the cellular gatekeeper for growth and division
26. Control of apoptosis and mitotic spindle checkpoint by survivin
27. Expression of a novel anti-apoptosis gene, survivin, correlated with tumour cell apoptosis and p53 accumulation in gastric carcinomas
28. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation
29. Molecular technology and pancreatic cancer
30. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
31. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients
32. A novel antisense nudeotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
33. Antibody response to the tumour-associated inhibitor of apoptosis protein survivin in cancer patients
34. Expression of the anti-apoptosis gene, survivin, predicts death from recurrent colorectal carcinoma
35. Commentary on: Expression of survivin and its relationship to loss of apoptosis in breast carcinoma
36. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival following curative resection of stage II colorectal carcinomas
37. Expression of surviving is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors
38. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH)
39. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: A comparative study with receiver operating characteristic analysis
40. Bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: Association with clinical outcome
41. Urine detection of survivin and diagnosis of bladder cancer
42. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation
43. Tumor content of the anti-apoptosis molecule survivin and recurrence of bladder cancer
44. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
45. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas
46. Pancreaticobiliary cancer: The future aspects of medical oncology
47. Characterization of the expanded T cell population in infectious mononucleosis: Apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status
48. Periampullary adenocarcinoma. Analysis of 5-year survivors